BioinformaticsbioRxivPreprint
Peptide therapeutic leads for multi-target inhibition of inflammatory cytokines in Inflammatory Bowel Disease - computational design and in-vitro validation
Tomer Tsaban, Gali Kariv-Attias, Alisa Khramushin…·Betty Schwartz
This study computationally designs and validates peptides that inhibit key inflammatory cytokines in IBD, showing reduced cytokine release in vitro.
DOI 10.1101/2024.08.27.609829